Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M735Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M--EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)27.5Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book3.010-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %0.8PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M4,600,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with IHE

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

IHE is held by these investors:



IHE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Rapps, MichaelDirector, Director or Senior Officer of 10% Securi 2017-01-16Buy1,200$9.481584.7view
Gridley, Anthony RonaldSenior Officer 2017-01-16Sell1,800$16.94842.8view
Dinwoodie, Tyler Wayne PaulSenior Officer 2017-01-16Buy4,000$0.1793847.06view
Brown, Mark ThomasDirector 2017-01-16Sell29,300$1.3611643.38view
Bebek, IvanDirector 2017-01-16Buy8,990$3.384625.15view
smith, laurie james10% Security Holder, Director, Senior Officer 2017-01-16Buy7,500$0.4138853.66view
MEHR, JEFFREYSenior Officer 2017-01-13Sell50,000$27.91472.23view
Squibb, Geoffrey WayneDirector 2017-01-13Buy267$6.272447.21view
Smith, DavidSenior Officer 2017-01-13Sell15,000$60.38164.51view
Rowlands, William BruceDirector, Senior Officer 2017-01-13Buy20,000$0.15106373.33view

Quarterly/Annual Reports about IHE:

    News about IHE:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Why investors flipped 180 on health care stocks today: NYSE trader Jun 23 2017
    Medical groups diagnose GOP health care bill: It’s not well Jun 23 2017
    Does Valeant Pharmaceuticals Intl Inc (VRX) Stock Have a Bull Case? Jun 22 2017
    Why one Wall Street strategist is cautious on techs and financials Jun 21 2017
    FDA Approves Eli Lilly’s Humalog Junior KwikPen Jun 19 2017
    What Happened to Pfizer’s Valuation after 1Q17? Jun 07 2017
    Performance of Eli Lilly’s Oncology Products in 1Q17 Jun 02 2017
    Inside Bristol-Myers Squibb’s Valuation after the 1Q17 Earnings May 18 2017
    The Latest Market Trends Every Biopharma Investor Needs to Know May 17 2017
    Pfizer’s Corporate and Pipeline Developments in 1Q17 May 09 2017
    Pfizer: Why Revenues Fell in 1Q17 for Some Products May 08 2017
    Analyzing Pfizer’s 1Q17 Earnings May 05 2017
    Analysts’ Ratings and Recommendations for Bristol-Myers Squibb Apr 27 2017
    Why medical device stocks may rise if Obamacare is repealed Apr 24 2017
    Why some investors aren't thrilled about Becton Dickinson buying C.R. Bard Apr 24 2017
    Stocks soar after French elections ahead of busiest earnings week in 10 years Apr 24 2017
    How Will Eli Lilly’s Alimta and Other Oncology Products Perform? Apr 21 2017
    Johnson & Johnson’s Pharmaceuticals Segment’s 1Q17 Earnings Apr 21 2017
    Lackluster J&J Q1 Pushes Healthcare ETFs Down Apr 19 2017
    The Larger Aims of Obamacare: An Overview Apr 11 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat

    {{numOfNotice}}